Cell Therapy : cGMP Facilities and Manufacturing /

This new edition presents a fully-updated and expanded look at current Good Manufacturing Practice (cGMP) for cell therapy products. It provides a complete discussion of facility design and operation including details specific to cord blood banking, cell processing, vector production and qualificati...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Gee, Adrian P. (Editor)
Format: eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2022.
Edition:2nd ed. 2022.
Subjects:
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • Part 1. Regulatory.-1. Regulation of Cell Therapy in the United States.-2. Regulatory Landscape and Emerging Trends In Advanced Therapies Manufacturing: An EU Perspective.-3. Australian Cellular Therapy Regulations
  • 4. Landscape for Regenerative Medicine Manufacturing in Japan
  • 5. GLP Regulations for Non-clinical studies
  • 6. Ethical Considerations in Cell Therapy
  • 7. Investigational New Drug Applications for Cell Therapy Products
  • 8. FDA Inspections
  • 9. Commercialization of Investigational Cell Therapy Products
  • Part 2 Quality Systems
  • 10. The Meaning of Quality
  • 11. Development and Maintenance of a Quality Program
  • 12. Quality Control of Cellular Therapy Products and Viral Vectors
  • 13. Quality Management Software - Q-Pulse
  • 14. Selection of Contract Manufacturing and Testing Organizations
  • Part 3 Facility Design
  • 15. Introduction: Facility Design
  • 16. PACT CPFs - Examples Describing Different Cell Processing Facility Designs
  • 17. Design and Operation of a Multiuse GMP Facility at the City of Hope
  • 18. Design and Operation of a Multiuse GMP Facility at the University of Miami
  • 19. Design of a New Academic GMP Facility for Today and Beyond at the Dana-Farber Cancer Institute
  • 20. Design and Licensure of an American Cord Blood Bank
  • 21. Indiana University Vector Production Facility (IUVPF)
  • 22. Qualification and Commissioning of a New GMP Facility
  • Part 4 Facility Infrastructure
  • 23. Environmental Monitoring
  • 24. GMP Facility Cleaning and Maintenance
  • 25. GMP Documentation
  • 26. Process Validation
  • 27. Equipment Qualification
  • 28. Vendor Qualification and Supply Management
  • 29. Staffing, Training and Competency
  • Part 5 Product Management
  • 30. Product Accessioning, Tracing and Tracking
  • 31. ISBT 128 in Labeling of Cellular Therapy Products
  • 32. Product Processing, Manufacturing and Administration
  • 33. Transport and Shipment of Cellular and Gene Therapy Products
  • 34. Regenerative Medicine: The Newest Cellular Therapy
  • 35. Cellular Therapy Applications for COVID-19
  • Part 6 Professional Standards and Support Organizations
  • 36. Professional Standards for Cellular Therapy: The Foundation for the Accreditation of Cellular Therapy (FACT)
  • 37. AABB Cell Therapy Standards
  • 38. USP Standards for Cell-based Therapies
  • 39. The Role of the National Institute of Standards Measurement Assurance for Cell Therapies
  • 40. National Science Foundation Engineering Research Center for Cell Manufacturing Technologies (CMaT)
  • 41. Financial Considerations for Academic GMP Facilities
  • 42. Governmental Support Opportunities for Cellular and Gene Therapies in the United States.